About: COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
Creator	Amar, E Bendayan, M Boitrelle, F Bouker, A Delalande, C El Osta, R Hamdi, S Huyghe, E Lejeune, H Leroy, C Perrin, J Plotton, I Pons, H Robin, G Soufir, J.-C
Source	Medline; PMC
abstract	SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) metamorphosed our medical practice. In early June 2020, more than 6,400,000 COVID-19 (coronavirus-19 disease) cases were diagnosed across the world and more than 380,000 deaths were linked to COVID-19. Many medical symptoms of COVID-19 were reported. We will focus, here, on potential impacts of COVID-19 on men’s andrological health. Our society (French-speaking society of andrology, SALF) also emitted some recommendations in the andrological management of men infected by SARS-CoV-2. First, considering the fever and the potential presence of SARS-CoV2 in semen, SALF recommends waiting for 3 months (duration of one spermatogenesis cycle and epididymal transit) before re-starting ART in the case of men diagnosed COVID-19 positive. Whatever the nature of testosterone and COVID-19 relationships, we recommend an andrological examination, sperm parameters, and hormonal evaluation at the time of the COVID-19 is diagnosed, and several months later. Furthermore, we are concerned by the potential morbid-mortality of the COVID-19, which mainly affects men. This “andrological bias”, if proven, must be reduced by specific andrological diagnosis, therapeutic and prophylactic measures. Research in this direction must be substantiated and financially supported over the next few months (years).
has issue date	2020-07-13(xsd:dateTime)
bibo:doi	10.1186/s12610-020-00106-4
bibo:pmid	32685170
has license	cc-by
sha1sum (hex)	ca9dc7c3fbea5535b41186085bf73ae11aee8397
schema:url	https://doi.org/10.1186/s12610-020-00106-4
resource representing a document's title	COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
has PubMed Central identifier	PMC7355134
has PubMed identifier	32685170
schema:publication	Basic Clin Androl
resource representing a document's body	covid:ca9dc7c3fbea5535b41186085bf73ae11aee8397#body_text
is schema:about of	named entity 'focus' named entity 'emitted' named entity 'fever' named entity 'French-speaking' named entity 'medical' named entity 'positive' named entity 'June' named entity 'Recommendations' named entity 'andrology' named entity 'COVID-19' named entity 'MEDICAL PRACTICE' named entity 'NATURE' named entity 'POTENTIAL' named entity 'SARS-CoV-2' named entity 'men' named entity 'diagnosis' named entity 'duration' named entity 'First' named entity 'impacts' named entity 'men' named entity 'infected' named entity 'COVID' named entity 'andrology' named entity 'SARS-CoV2' named entity 'COVID-19' named entity 'COVID-19' named entity 'fever' named entity 'COVID-19' named entity 'COVID-19' named entity 'testis' named entity 'sperm parameters' named entity 'TMPRSS2' named entity 'gene' named entity 'protein' named entity 'COVID-19' named entity 'TMPRSS2' named entity 'COVID-19' named entity 'seminal vesicle' named entity 'seminal fluid' named entity 'leukocyte' named entity 'Sertoli cells' named entity 'COVID-19' named entity 'ART' named entity 'assisted reproductive technologies' named entity 'ACE2 receptor' named entity 'sperm parameters' named entity 'SARS' named entity 'SARS-CoV-2' named entity 'blood-testis barrier' named entity 'orchitis' named entity 'SARS-Cov-2' named entity 'hypogonadism' named entity 'COVID-19' named entity 'semen' named entity 'SARS-CoV-2' named entity 'TMPRSS2' named entity 'ACE2 receptor' named entity 'prostate cancer' named entity 'serine protease' named entity 'mois' named entity 'SARS-CoV2' named entity 'Europe' named entity 'spike (S) protein' named entity 'assisted reproductive technologies' named entity 'SARS-CoV-2' named entity 'Social distancing' named entity 'andrology'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software